Characterizing recombinant protein and its fragmentation by top-down mass spectrometry
Journal of Pharmaceutical and Biomedical Analysis · 2026
DOI: 10.1016/j.jpba.2025.117157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Zhen Long und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thermo Fisher Scientific Corporation, Beijing 100080, China. Hauptthemen laut MEDLINE: Recombinant Proteins, Collagen, Mass Spectrometry. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
This study establishes a top-down mass spectrometry method for evaluating the structural integrity and fragmentation profiles of recombinant proteins. Three representative samples were analyzed: recombinant collagen 1 (RC1, 15.037 kDa; no disulfide bonds), recombinant collagen 2 (RC2, 49.859 kDa; no disulfide bonds), and interferon α2b (19.497 kDa; two disulfide bonds). Both targeted MS²-based, and data-dependent acquisition (DDA)-based top-down workflows were established to accommodate different analytical needs. The developed top-down strategies enabled direct sequencing of proteins with highly repetitive sequences, which pose challenges for bottom-up methods. The findings of this study provide insights into the identification of proteins with molecular weights (MWs) below 50 kDa. First, for proteins with MWs below 12 kDa, DDA-based top-down analysis utilizing HCD fragmentation provides high-throughput identification with 50 % (eg. of 27 fragments for protein RC1). Second, for proteins with MWs greater than 12 kDa, target-MS2-based top-down approaches improve sequence coverage, achieving up to 49.5 % for RC2 by combining three dissociation strategies. Third, for proteins containing disulfide bonds, disulfide reduce pretreatment prior to MS analysis is necessary to achieve improved residue cleavage coverage. Overall, this work demonstrates that top-down mass spectrometry provides complementary data to bottom-up methods, delivering crucial insights for comprehensive characterization of therapeutic recombinant proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thermo Fisher Scientific Corporation, Beijing 100080, China.
- National Institutes for Food and Drug Control, Beijing 100050, China.
- Thermo Fisher Scientific, San Jose, CA, USA.
- State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China. Electronic address: xluo@ipe.ac.cn.
- National Institutes for Food and Drug Control, Beijing 100050, China. Electronic address: taolei01@nifdc.org.cn.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Long, Z., Pei, D., Zhu, X., Liu, W., Luo, X., Fan, W., & Tao, L. (2026). Characterizing recombinant protein and its fragmentation by top-down mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.117157
Vancouver
Long Z, Pei D, Zhu X, Liu W, Luo X, Fan W, et al. Characterizing recombinant protein and its fragmentation by top-down mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2025.117157
BibTeX
@article{Long2026,
author = {Long, Zhen and Pei, Dening and Zhu, Xiang and Liu, Weijing and Luo, Xi and Fan, Wenhong and Tao, Lei},
title = {Characterizing recombinant protein and its fragmentation by top-down mass spectrometry},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2026},
doi = {10.1016/j.jpba.2025.117157}
}
EUVIMED